• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型炎症小体和氧化调节剂在帕金森病中的作用:一项前瞻性研究。

Novel inflammasome and oxidative modulators in Parkinson's disease: A prospective study.

机构信息

Department of Neurology, Institute of Neurosciences Kolkata, Kolkata, India; Department of Physiology, University of Calcutta, Kolkata, India.

Department of Neurology, Institute of Neurosciences Kolkata, Kolkata, India.

出版信息

Neurosci Lett. 2022 Aug 24;786:136768. doi: 10.1016/j.neulet.2022.136768. Epub 2022 Jun 30.

DOI:10.1016/j.neulet.2022.136768
PMID:35780939
Abstract

INTRODUCTION

The etiopathogenesis of Parkinson's disease (PD) is not clear. Yet, it seems likely that inflammation as well as oxidative stress plays a major role in the disease pathogenesis. Based on our previous findings, we aimed to investigate prospective changes in peripheral inflammasome and oxidative modulators in relation to the progression of motor symptoms and severity of PD.

METHODS

Levels of inflammatory and oxidative markers in the serum of PD patients and healthy controls were estimated by quantitative ELISA and spectrophotometric methods at the baseline and at the end of one year.

RESULTS

In PD patients, serum NLRP3 inflammasome and IL-1β levels increased significantly over a year, compared to the baseline. The average enzymatic activity of serum SOD1 was also augmented at one-year follow-up. Alongside these serummarker changes, the mean motorseverity of this patient cohort worsened over the time period.

CONCLUSION

This pioneering study identified a novel association of peripheral inflammatory and oxidative markers with the progression of PD. Correlation of these serum proteins with the central pathological changes in PD and disease severity in a prospective manner might be useful not only for prognostication, but for understanding disease mechanisms and for planning future therapeutic strategies.

摘要

简介

帕金森病(PD)的发病机制尚不清楚。然而,炎症和氧化应激似乎在疾病发病机制中起主要作用。基于我们之前的研究结果,我们旨在研究与运动症状进展和 PD 严重程度相关的外周炎性小体和氧化调节剂的前瞻性变化。

方法

通过定量 ELISA 和分光光度法在基线和一年后测量 PD 患者和健康对照组血清中的炎症和氧化标志物水平。

结果

与基线相比,PD 患者的血清 NLRP3 炎性小体和 IL-1β 水平在一年内显著增加。在一年的随访中,血清 SOD1 的平均酶活性也增加了。随着这些血清标志物的变化,该患者队列的平均运动严重程度在一段时间内恶化。

结论

这项开创性的研究确定了外周炎症和氧化标志物与 PD 进展之间的新关联。这些血清蛋白与 PD 中枢病理变化和疾病严重程度的前瞻性相关性不仅有助于预测,还有助于理解疾病机制和规划未来的治疗策略。

相似文献

1
Novel inflammasome and oxidative modulators in Parkinson's disease: A prospective study.新型炎症小体和氧化调节剂在帕金森病中的作用:一项前瞻性研究。
Neurosci Lett. 2022 Aug 24;786:136768. doi: 10.1016/j.neulet.2022.136768. Epub 2022 Jun 30.
2
Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.NLRP3 炎性小体的系统激活和血浆 α-突触核蛋白水平与帕金森病的运动严重程度和进展相关。
J Neuroinflammation. 2020 Jan 8;17(1):11. doi: 10.1186/s12974-019-1670-6.
3
Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.靶向帕金森病中微胶质细胞α-突触核蛋白/TLRs/NF-κB/NLRP3 炎性小体轴
Front Immunol. 2021 Oct 8;12:719807. doi: 10.3389/fimmu.2021.719807. eCollection 2021.
4
The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.NLRP3 炎性小体/细胞焦亡激活的机制及其在帕金森病中的作用。
Int Immunopharmacol. 2019 Feb;67:458-464. doi: 10.1016/j.intimp.2018.12.019. Epub 2018 Dec 27.
5
A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.天然产物在 NLRP3 炎性小体介导的阿尔茨海默病和帕金森病神经炎症中的新治疗策略。
Int J Mol Sci. 2021 Jan 28;22(3):1324. doi: 10.3390/ijms22031324.
6
P2X7 receptor/NLRP3 inflammasome complex and α-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-naïve Parkinson's disease.P2X7 受体/NLRP3 炎性小体复合物和α-突触核蛋白在外周血单核细胞中的研究:一项新诊断、未经治疗的帕金森病的前瞻性研究。
Eur J Neurol. 2021 Aug;28(8):2648-2656. doi: 10.1111/ene.14918. Epub 2021 Jun 2.
7
Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.NIM811 抑制鱼藤酮诱导的细胞模型中 NLRP3 炎性小体、细胞焦亡和细胞死亡在帕金森病体外模型中的作用。
Neurodegener Dis. 2020;20(2-3):73-83. doi: 10.1159/000511207. Epub 2020 Nov 11.
8
MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.微小RNA-7靶向NOD样受体蛋白3炎性小体以调节帕金森病发病机制中的神经炎症。
Mol Neurodegener. 2016 Apr 16;11:28. doi: 10.1186/s13024-016-0094-3.
9
Genkwanin suppresses MPP-induced cytotoxicity by inhibiting TLR4/MyD88/NLRP3 inflammasome pathway in a cellular model of Parkinson's disease.根皮苷通过抑制 TLR4/MyD88/NLRP3 炎性小体通路抑制帕金森病细胞模型中的 MPP+诱导的细胞毒性。
Neurotoxicology. 2021 Dec;87:62-69. doi: 10.1016/j.neuro.2021.08.018. Epub 2021 Sep 2.
10
The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.昼夜节律钟蛋白 Rev-erbα 通过小胶质细胞 NLRP3 炎性小体提供神经保护并减轻帕金森病的神经炎症。
J Neuroinflammation. 2022 Jun 6;19(1):133. doi: 10.1186/s12974-022-02494-y.

引用本文的文献

1
The pyroptosis mediated biomarker pattern: an emerging diagnostic approach for Parkinson's disease.焦亡介导的生物标志物模式:帕金森病的一种新兴诊断方法。
Cell Mol Biol Lett. 2024 Jan 3;29(1):7. doi: 10.1186/s11658-023-00516-y.
2
Cytokine activity in Parkinson's disease.帕金森病中的细胞因子活性。
Neuronal Signal. 2023 Dec 4;7(4):NS20220063. doi: 10.1042/NS20220063. eCollection 2023 Dec.
3
Targeting NLRP3 inflammasome for neurodegenerative disorders.针对神经退行性疾病的 NLRP3 炎性小体。
Mol Psychiatry. 2023 Nov;28(11):4512-4527. doi: 10.1038/s41380-023-02239-0. Epub 2023 Sep 5.